Corporate Announcement
Security Code : 531633    Company : LINCOLN    
 
Announcement under Regulation 30 (LODR)-Scheme of ArrangementDownload PDF Download XBRL
  Exchange Received Time  07/12/2019 16:37:35         Exchange Disseminated Time   07/12/2019 16:37:49              Time Taken   00:00:14
In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that the meeting of Board of Directors of Lincoln Pharmaceuticals Limited (the "Company") held on today, i.e. December 7, 2019 and considered and decided following business;

1. It is decided to withdraw the Scheme of amalgamation between Lincoln Parenteral Limited ("Transferor Company") and Lincoln Pharmaceuticals Limited ("Transferee Company") as approved by the Board of Directors in its meeting held on September 19, 2019 and
2. Approved the Scheme of Amalgamation between Lincoln Parenteral Limited ("Transferor Company") and Lincoln Pharmaceuticals Limited ("Transferee Company") ("Scheme"), subject to all requisite approval. The Appointed Date for the Scheme is April 01, 2019.
 

Disclaimer

Back To Announcements